Read end-to-end by a FundingAtlas editor against the official source.
Quick answer
NIHR Invention for Innovation (i4i) Product Development Awards is a UK funding programme. UK SMEs, NHS organisations or universities developing medical devices, IVDs, or technology-dependent interventions for the NHS. Funding: Up to £1.5m. Med-tech SMEs and NHS-led teams developing devices for clinical adoption. It is published as a standard listing — verify current rounds and full criteria on the official source before applying.
Funding amount
Up to £1.5m
Region
United Kingdom
Stage
Growth
Provider
National Institute for Health and Care Research
Advisor view
This is a research-led programme — funding follows scientific quality and credible delivery. Industry applicants underestimate how rigorous the assessment is.
Frequently asked questions
- Who is NIHR Invention for Innovation (i4i) Product Development Awards really for?
- It works best for organisations that already meet the eligibility test on paper and have the operational maturity to deliver — not for businesses hoping the application will force them to formalise.
- What are the most common reasons applications are rejected?
- Weak evidence, eligibility misses, and applications that read as business as usual rather than the specific intent of the scheme. Most rejections are avoidable with earlier preparation.
- Can early-stage startups apply?
- Sometimes — but the strongest applicants usually have at least minimum trading history, a defined plan and the team to deliver. If you are pre-revenue with no plan, expect to be too early.
- How competitive is it?
- Demand routinely outstrips supply for the high-profile UK programmes. Treat any competitive call as a serious bid that needs four to six weeks of preparation, not a weekend.
- What should I prepare before I apply?
- A short written summary of what you are doing and why it qualifies, your latest accounts or forecasts, and any partner or evidence the scheme expects. Get adviser sign-off before submission.
- What happens after a successful application?
- Expect monitoring, reporting and milestone evidence. Plan the reporting cadence and internal owner before the funding lands, not afterwards.
Who it's for
Med-tech SMEs and NHS-led teams developing devices for clinical adoption.
Usually too early when
Advisor signal
You have no research question or hypothesis, no credible PI, no host organisation, or no defined research plan.
Eligibility
UK SMEs, NHS organisations or universities developing medical devices, IVDs, or technology-dependent interventions for the NHS.
Common reasons applications fail
Weak research question, immature methodology, missing collaborators, governance gaps, or an ineligible host.
What improves your odds
A credible principal investigator with track record, an eligible host organisation, a clear research question, and an engaged commercial or clinical partner where required.
Typical successful applicant
A research-active university, NHS organisation, charity or research-intensive SME with experienced investigators and the governance to manage a research grant.
Common misconceptions
These are not innovation grants in the Innovate UK sense — they fund research, not productisation. Eligibility, IP and publication rules differ materially.
What comes next
Plan the translational pathway from the start — successful grants often hinge on whether the next stage is identified.
Funding context
Pairs with translational funding once underpinning research has matured.
Related routes
Industries
Objectives
Regions